Similar articles

• [Myelin diseases affecting both the central and the peripheral nervous system].

  Hagen K, Mellgren SI, Bovim G. Hagen K, et al. Tidsskr Nor Laegeforen. 1998 Sep 30;118(23):3600-2. Tidsskr Nor Laegeforen. 1998. PMID: 9820004 Review. Norwegian.
• [A case of anti-neurofascin 155 antibody-positive combined central and peripheral demyelination successfully treated with plasma exchange].

  Shimizu M, Koda T, Nakatsuji Y, Ogata H, Kira JI, Mochizuki H. Shimizu M, et al. Rinsho Shinkeigaku. 2017 Jan 31;57(1):41-44. doi: 10.5692/clinicalneurol.cn-000964. Epub 2016 Dec 23. Rinsho Shinkeigaku. 2017. PMID: 28025411 Japanese.
• [Demyelinating disease affecting both central and peripheral nervous system].

  Carra-Dallière C, Mania A, Carlander B, Camu W, Juntas-Morales R. Carra-Dallière C, et al. Rev Neurol (Paris). 2011 Dec;167(12):921-5. doi: 10.1016/j.neurol.2010.12.005. Epub 2011 May 18. Rev Neurol (Paris). 2011. PMID: 21596409 French.
• [Concepts and epidemiology of combined central and peripheral demyelination].

  Ogata H. Ogata H. Nihon Rinsho. 2015 Sep;73 Suppl 7:341-6. Nihon Rinsho. 2015. PMID: 26480723 Japanese. No abstract available.
• [Diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy].

  Kubori T, Kaji R. Kubori T, et al. Nihon Naika Gakkai Zasshi. 1998 Apr 10;87(4):623-8. Nihon Naika Gakkai Zasshi. 1998. PMID: 9627469 Review. Japanese. No abstract available.